Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 27, 2020

View Archived Issues

Researchers achieve the reversal of HIV and SIV latency in vivo

Chromosome amplification drives cancer progression via effects on secretion

Fat or fiber, cFAP activation is problematic for heart

Novel panaxatriol derivative shows efficacy in rat model of MI/R injury

Phase Ia/b data presented for PL-MLP in patients with metastatic CRC

ALPN-101 demonstrates efficacy in preclinical models of chronic IBD

FDA issues clinical hold on the phase III POLAR program of PledOx

Colorectal cancer among those affected by periostin

CEPI awards funding to support development of vaccines against coronavirus 2019-nCoV

Jiangsu Hengrui Medicine, Shanghai Hengrui patent TLR8 agonists

Incyte describes new adenosine A2A and/or A2B receptor antagonists

PIKfyve inhibitors identified at MFMER, Sanford Burnham Prebys Medical Discovery Institute

Protein cereblon inhibitors discovered at Kymera Therapeutics

The University of Minnesota presents psi-glutathione compounds

PDE3A influences endothelial function and risk of ischemic stroke

Phase III study of AKP-01 spray in mild to moderate plaque psoriasis meets primary endpoint

Pivotal DESTINY-Gastric01 trial of DS-8201 meets primary endpoint

CStone begins phase III study of CS-1003 in advanced hepatocellular carcinoma

Dynacure studies DYN-101 in phase I/II trial for centronuclear myopathies

Brilinta improves outcomes after acute ischemic stroke or TIA in phase III trial

Phase I results with EPX-100 pave way for phase II studies in Dravet syndrome

Phase III BREEZE-AD4 trial of baricitinib in atopic dermatitis meets primary endpoint

Daiichi Sankyo begins phase I study in Japan with DS-2741a for atopic dermatitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...